| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |